See all treatments in the PatientsLikeMe system shared by patients just like you.
| 7 Patients currently take Rivastigmine | |
| 2 Patients stopped taking Rivastigmine |
Brand Names:
Exelon
What is Rivastigmine?
Rivastigmine is a cholinergic agent that was developed by Novartis for the treatment of mild to moderate dementia of the Alzheimer’s type. Rivastigmine has been available in capsule and liquid formulations since 1997. In 2006, it became the first product approved for Parkinson's disease dementia.
Read more...
| Brain fog | |
|---|---|
| Memory problems | |
| Stiffness/spasticity |
| Did not seem to work | |
|---|---|
| Side effects too severe | |
| Not indicated |